You are here

AstraZeneca

Soriot skipping over to Teva ahead of MYSTIC results?

BioPharma Dive

Thu, 07/13/17 - 05:36 pm

Teva Pharmaceutical

Terrible optics: AstraZeneca shares take a hit following report that CEO Soriot is moving to Teva

Endpoints

Thu, 07/13/17 - 08:53 am

Teva Pharmaceutical

AstraZeneca's CEO Soriot to join Israeli drugs company Teva: report

Reuters

Wed, 07/12/17 - 04:27 pm

Teva Pharmaceutical

AstraZeneca Expects Brilinta to Become a Blockbuster Therapy in 2017

Market Realist

Wed, 07/12/17 - 10:01 am

What the FDA's Hold on Three Merck Studies Means for Other Drug Makers

TheStreet.com

Sun, 07/9/17 - 07:44 pm

clinical trials

Multiple Myeloma

Bristol-Myers Squibb

Ex-AstraZeneca executive Luke Miels accuses CEO Soriot of threatening him for taking GSK job

Fierce Pharma

Thu, 07/6/17 - 09:48 am

AstraZeneca Expected to Report Fall in Revenues in 2017

Market Realist

Mon, 07/3/17 - 09:44 am

Investors — and AstraZeneca CEO Pascal Soriot — are getting a tad nervous as MYSTIC data loom

Endpoints

Thu, 06/29/17 - 09:23 am

immuno-oncology

clinical trials

AstraZeneca's struggling FluMist loses out on crucial CDC vaccine backing—again

Fierce Pharma

Tue, 06/27/17 - 11:48 pm

Pfizer Fueling Growth Of Competitors' Pipelines

Forbes

Tue, 06/27/17 - 10:02 am

Clovis Oncology

Puma Biotechnology

AstraZeneca at Cannes: Healthcare delivery's speeding away from pharma's marketing model

Fierce Pharma

Mon, 06/26/17 - 11:57 am

pharma marketing

For AstraZeneca, Cancer Drug Weighs on Go-It-Alone Stand

FOX Business

Tue, 06/20/17 - 09:41 am

GSK's new pharma head to join in September after AstraZeneca tussle

Yahoo/Reuters

Mon, 06/19/17 - 11:34 pm

New test may turn AZ's Lynparza into precision drug for prostate cancer

Yahoo/Reuters

Mon, 06/19/17 - 07:16 am

prostate cancer

Can AstraZeneca Keep Up As Clovis, Tesaro Unveil Blockbuster Drugs?

Investors Business Daily

Mon, 06/19/17 - 07:16 am

PARP inhibitors

AstraZeneca, Boehringer cry 'no class effect' after Johnson & Johnson's Invokana doubles amputations in study

Fierce Pharma

Wed, 06/14/17 - 09:00 pm

Boehringer Ingelheim

ADA: Merck, Pfizer notch success, but late with SGLT-2 data

BioPharma Dive

Tue, 06/13/17 - 12:15 pm

SGLT2 inhibitor

Boehringer Ingelheim

Regulus Dumps Two Drugs, AstraZeneca Sends Back Another, Shares Fall

Xconomy

Mon, 06/12/17 - 10:08 pm

AstraZeneca to sell Zomig migraine drug rights

Marketwatch

Wed, 06/7/17 - 12:15 pm

ASCO17: AstraZeneca pumps up expectations on near-term cancer drug wins, looking to shed a rep for failure

Endpoints

Tue, 06/6/17 - 09:44 am

Pages